Abstract
Transcatheter treatment of severe aortic stenosis has progressively evolved from since the first implant in humans performed by Cribier in 2002. The use of retrograde transfemoral and transapical accesses have been well standardised. With the technical improvements introduced into the devices, the trans-aortic route has increasingly been used. This new approach may have many advantages for the treatment of inoperable or high-risk patients. Our group started to use this technique in 2013, and it has become the preferred procedure for us, instead of the transapical approach. In this article, a step by step description is presented of our trans-aortic technique and its main advantages and disadvantages.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
